CH Biotech R&D Co., Ltd.
TAI: 6534.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- CEO
- Wen Ren Chen
- Employees
- 200
- Headquarters
- Nantou City, Taiwan
- IPO year
- 2023
- Market cap
- NT$9.8B
- Website
- https://www.chbio.com
Loading 6534…
Loading profile data…Frequently asked questions about 6534
What does CH Biotech R&D Co., Ltd. (6534.TW) do?
CH Biotech R&D Co., Ltd., develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally. It offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd. was incorporated in 2013 and is headquartered in Nantou City, Tai...
Where does 6534.TW trade?
CH Biotech R&D Co., Ltd. (6534.TW) trades on the Taiwan Stock Exchange.
What sector is 6534.TW in?
CH Biotech R&D Co., Ltd. (6534.TW) operates in the Basic Materials sector, specifically in the Agricultural Inputs industry.
Who is the CEO of CH Biotech R&D Co., Ltd.?
Wen Ren Chen is the chief executive officer of CH Biotech R&D Co., Ltd. (6534.TW).
Where is CH Biotech R&D Co., Ltd. headquartered?
CH Biotech R&D Co., Ltd. is headquartered in Taiwan.
Does 6534.TW pay a dividend?
Yes — CH Biotech R&D Co., Ltd. (6534.TW) paid a trailing twelve-month dividend of TWD 4.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6534.TW go public?
CH Biotech R&D Co., Ltd. (6534.TW) completed its initial public offering in 2023.